19 Patient-reported outcomes from a phase 2, randomised trial evaluating the safety and efficacy of pozelimab and cemdisiran in patients with paroxysmal nocturnal haemoglobinuria

Hartford, Christopher ; Nguyen, Quang P. ; Sherman, Steven ; Pavani, Rodrigo ; Aurand, Lisa ; Rofail, Diana ; Kelly, Richard J.

Immunobiology (1979), 2023-09, Vol.228 (5), p.152477, Article 152477 [Periódico revisado por pares]

Elsevier GmbH

Texto completo disponível